The ARDVAARC study: real-world outcomes and the utility of bleeding risk scores in patients who require anticoagulation following percutaneous coronary intervention (PCI)
25 August 2018 (00:00 - 00:00)
Organised by:
About the speaker

Guy's and St Thomas' NHS Trust Foundation Trust, London (United Kingdom of Great Britain & Northern Ireland)
9 More presentations in this session
Doctor L. Wang (Singapore, SG)
Doctor M. Brockmeyer (Duesseldorf, DE)
Access the full session
The Event
ESC Congress 2018
25 August - 29 August 2018
You may be interested in
Congress Presentation
Congress Presentation

